Medebo
ActiveSummary
Medebo has been active since 1982 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €141,004. Equity is growing by about 6.6% per year across the filed financial years. Its solvency ranks better than 88% of 4,298 sector peers (NACE 74, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
29-07
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
23-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
2023
22-12
NBB filing
Annual accounts filed
financial year 2022 · micro format · 144 days late
2022
31-12
Financial
Weakest financial yearnet €126,238 ▼44%
Net result drops to €126,238, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €2mequity €2.1m ▲6.4%
A profit in every financial year since 2018 builds equity to €2.1m.
19-07
NBB filing
Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial
Highest result from 2018 to 2025net €225,552 ▲37.5%
Operating result €276,134, net result €225,552, both a record.
26-07
NBB filing
Annual accounts filed
financial year 2020 · micro format
2020
05-06
NBB filing
Annual accounts filed
financial year 2019 · micro format
2019
19-06
NBB filing
Annual accounts filed
financial year 2018 · micro format
2018
15-06
NBB filing
Annual accounts filed
financial year 2017 · micro format
2017
01-08
NBB filing
Annual accounts filed
financial year 2016 · micro format · 1 day late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 43 annual accounts filed, the latest 10 are here; all 43 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.